Cargando…

Fentanyl buccal tablet for breakthrough cancer pain in clinical practice: results of the non-interventional prospective study ErkentNIS

PURPOSE: Several patients with advanced cancer suffer from breakthrough cancer pain (BTcP). BTcP is pain exacerbation despite opioid baseline therapy. Fentanyl buccal tablet (FBT) is a rapid-onset opioid for the treatment of BTcP. The aim of this study is to document the feasibility of FBT in patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masel, Eva Katharina, Landthaler, Robert, Gneist, Margit, Watzke, Herbert Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752740/ https://www.ncbi.nlm.nih.gov/pubmed/28849261 http://dx.doi.org/10.1007/s00520-017-3853-y

Ejemplares similares

Fentanyl Buccal Tablet for the Treatment of Breakthrough Pain: Pharmacokinetics of Buccal Mucosa Delivery and Clinical Efficacy
por: Darwish, Mona, et al.
Publicado: (2010)

Budget impact analysis of the fentanyl buccal tablet for treatment of breakthrough cancer pain
por: Darbà, Josep, et al.
Publicado: (2013)

Heart rate variability during treatment of breakthrough pain in patients with advanced cancer: a pilot study
por: Masel, Eva Katharina, et al.
Publicado: (2016)

A new transmucosal drug delivery system for patients with breakthrough cancer pain: the fentanyl effervescent buccal tablet
por: Freye, Enno
Publicado: (2008)

Fentanyl transmucosal tablets: current status in the management of cancer-related breakthrough pain
por: Prommer, Eric, et al.
Publicado: (2012)

Dose Proportionality of Fentanyl Buccal Tablet in Healthy Japanese Volunteers
por: Darwish, Mona, et al.
Publicado: (2008)

Predicting tolerability of high-dose fentanyl buccal tablets in cancer patients
por: Kwon, Mi-Young, et al.
Publicado: (2023)

Effects of Age Among Elderly Cancer Patients on Breakthrough Pain Management with Sublingual Fentanyl Tablets
por: Guitart, Jordi, et al.
Publicado: (2019)

Relative Bioavailability of Fentanyl Following Various Dosing Regimens of Fentanyl Buccal Tablet in Healthy Japanese Volunteers
por: Darwish, Mona, et al.
Publicado: (2008)

An Evaluation of Total Disintegration Time for Three Different Doses of Sublingual Fentanyl Tablets in Patients with Breakthrough Pain
por: Nalamachu, Srinivas
Publicado: (2013)

Extent of Fentanyl Accumulation Following Multiple Doses of Fentanyl Buccal Tablet 400 µg in Healthy Japanese Volunteers
por: Darwish, Mona, et al.
Publicado: (2008)

Fentanyl buccal soluble film (FBSF) for breakthrough pain in patients with cancer: a randomized, double-blind, placebo-controlled study
por: Rauck, R., et al.
Publicado: (2010)

Comparison of analgesia, adverse effects, and quality of life in cancer patients during treatment of procedural pain with intravenous morphine, fentanyl nasal spray, and fentanyl buccal tablets
por: Piotrowska, Wieslawa, et al.
Publicado: (2019)

Breakthrough Pain Management with Sublingual Fentanyl Tablets in Patients with Cancer: Age Subgroup Analysis of a Multicenter Prospective Study
por: Guitart, Jordi, et al.
Publicado: (2017)

Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication
por: Guitart, Jordi, et al.
Publicado: (2018)

Fentanyl Sublingual Spray for Breakthrough Pain in Cancer Patients
por: Zeppetella, Giovambattista
Publicado: (2013)

Safety and Efficacy of Oral Transmucosal Fentanyl Citrate Compared to Morphine Sulphate Immediate Release Tablet in Management of Breakthrough Cancer Pain
por: Bhatnagar, Sushma, et al.
Publicado: (2014)

Correction to: Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication
por: Guitart, Jordi, et al.
Publicado: (2018)

Role of intranasal fentanyl in breakthrough pain management in cancer patients
por: Leppert, Wojciech
Publicado: (2010)

Single-dose fentanyl sublingual spray for breakthrough cancer pain
por: Taylor, Donald R
Publicado: (2013)

Intranasal Fentanyl for Intervention-Associated Breakthrough Pain After Cardiac Surgery
por: Valtola, Antti, et al.
Publicado: (2021)

Initial titration with 200 μg fentanyl buccal tablets: a retrospective safety analysis in Korean cancer patients
por: Kwon, Mi-Young, et al.
Publicado: (2018)

Cost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment
por: Cortesi, Paolo Angelo, et al.
Publicado: (2017)

Retrospective qualitative pilot study incorporating patients’ personal life aspects on admission to palliative care: What should we know about patients to give them the best possible care?
por: Kitta, Anna, et al.
Publicado: (2019)

Single-Dose Pharmacokinetics of Fentanyl Buccal Soluble Film
por: Vasisht, Niraj, et al.
Publicado: (2010)

Efficacy, safety, and tolerability of fentanyl pectin nasal spray in patients with breakthrough cancer pain
por: Ueberall, Michael A, et al.
Publicado: (2016)

Breakthrough pain management using fentanyl buccal tablet (FBT) in combination with around-the-clock (ATC) opioids based on the efficacy and safety of FBT, and its relationship with ATC opioids: results from an open-label, multi-center study in Japanese cancer patients with detailed evaluation
por: Takigawa, Chizuko, et al.
Publicado: (2015)

Formulation and evaluation of mucoadhesive buccal tablets of aceclofenac
por: Koirala, Santosh, et al.
Publicado: (2021)

Efficacy and safety of fentanyl buccal for cancer pain management by administration through a soluble film: an update
por: Delgado-Guay, Marvin Omar
Publicado: (2010)

A phase II study on the efficacy and safety of procedural analgesia with fentanyl buccal tablet in cancer patients for the placement of indwelling central venous access systems
por: Bortolussi, R, et al.
Publicado: (2015)

Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain
por: Mercadante, S, et al.
Publicado: (2007)

In vivo bioavailability studies of sumatriptan succinate buccal tablets
por: Shivanand, K, et al.
Publicado: (2011)

Fabrication and In-vitro Evaluation of Buccal Mucoadhesive Tablet of Meloxicam
por: Arabi, Mahshid, et al.
Publicado: (2020)

Rapid acting fentanyl formulations in breakthrough pain in cancer. Drug selection by means of the System of Objectified Judgement Analysis
por: Janknegt, Robert, et al.
Publicado: (2018)

Establishing end-of-life boards for palliative care of patients with advanced diseases
por: Masel, Eva K., et al.
Publicado: (2018)

Migrate your mind: the role of palliative care in transcultural cancer treatment: A qualitative analysis
por: Roider-Schur, Sophie, et al.
Publicado: (2019)

Patients’ attitude and knowledge towards resuscitation and advance care planning at the palliative care unit
por: Unseld, Matthias, et al.
Publicado: (2019)

Risperidone mucoadhesive buccal tablets: formulation design, optimization and evaluation
por: Çelik, Burak
Publicado: (2017)

Patient Satisfaction with Fentanyl Pectin Nasal Spray in Breakthrough Cancer Pain Management During Radiotherapy for Head and Neck Cancer
por: Pointreau, Yoann, et al.
Publicado: (2020)

Managing NFS and NIS /
por: Stern, Hal
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_vl8ql3jqdpfd6md8p7hepfq63s